Abstract:Abstract Background Due to the lack of enough interaction data among compositions, targets and diseases, it is difficult to construct a complete network of Traditional Chinese Medicine (TCM) that comprehensively reflects active compositions and their synergistic network in terms of specific diseases. Therefore, mapping of the full spectrum of interaction between compounds and their targets is of central importance when we use network pharmacology approach to explore the therapeutic potential of the TCM. Methods To address this challenge, we developed a large-scale simultaneous interaction prediction approach (SiPA) integrated one interaction network based simple inference model (SIM), focusing on ‘logical relevance’ between compounds, proteins or diseases, and another compound-target correlation space based interaction prediction model (CTCS-IPM) that was built on the basis of the canonical correlation analysis (CCA) to estimate the position of compounds (or targets) in compound-protein correlated space. Then SiPA was applied to discover reliable multiple interactions for interaction network expansion of a TCM, compound Salvia miltiorrhiza . By means of network analysis, potential active compounds and their related network synergy underlying cardiovascular diseases were evaluated between expanded and original interaction networks. Part of new interactions were validated with existing experimental evidence and molecular docking. Results As evaluated with known test dataset, the established combination approach was proved to make highly accurate prediction, showing a well prediction performance for the SIM and a high recall rate of 85.2% for the CTCS-IPM. Then 710 pairs of new compound-target interactions, 24 pairs of new compound-cardiovascular disease interactions and 294 pairs of new cardiovascular disease-protein interactions were predicted for compound Salvia miltiorrhiza . Results of network analysis suggested the network expansion could dramatically improve the completeness and effectiveness of the network. Validation results of literature and molecular docking manifested that inferred interactions had good reliability. Conclusions We provided a practical and efficient way for large-scale inference of multiple interactions of TCM ingredients, which was not limited by the lack of negative samples, sample size and target 3D structures. SiPA could help researchers more accurately prioritize the effective compounds and more completely explore network synergy of TCM for treating specific diseases, indicating a potential way for effectively identifying candidate compound (or target) in drug discovery.

Relating Anatomical Therapeutic Indications by the Ensemble Similarity of Drug Sets.

A method for finding groups of related herbs in traditional chinese medicine

Measure Clinical Drug-Drug Similarity Using Electronic Medical Records.

Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources

Inferring Anatomical Therapeutic Chemical (ATC) Class of Drugs Using Shortest Path and Random Walk with Restart Algorithms

Concept-Based Semi-Automatic Classification of Drugs

Using the Distance Between Sets of Hierarchical Taxonomic Clinical Concepts to Measure Patient Similarity

Study of Drug Function Based on Similarity of Pathway Fingerprint

Deep fusion learning facilitates anatomical therapeutic chemical recognition in drug repurposing and discovery

Computational drug repositioning based on the relationships between substructure–indication

Improving Chemical Similarity Ensemble Approach in Target Prediction

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning

Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target

Systemic Similarity Analysis of Compatibility Drug-Induced Multiple Pathway Patterns in Vivo

Development of simultaneous interaction prediction approach (SiPA) for the expansion of interaction network of traditional Chinese medicine

Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations

Target Enhanced 2D Similarity Search by Using Explicit Biological Activity Annotations and Profiles

Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification

Measuring drug similarity using drug–drug interactions

Associating 197 Chinese Herbal Medicine with Drug Targets and Diseases Using the Similarity Ensemble Approach.

Quantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysis